Description:
Home Page: www.novartis.com
Lichtstrasse 35
Basel,
4056
Switzerland
Phone:
41 61 324 1111
Officers
| Name | Title |
|---|---|
| Dr. Vasant Narasimhan | Chief Exec. Officer |
| Mr. Harry Kirsch | Chief Financial Officer |
| Dr. Klaus Moosmayer Ph.D. | Chief Ethics, Risk & Compliance Officer |
| Ms. Karen L. Hale | Chief Legal Officer |
| Dr. Robert Kowalski Pharm.D. | Chief People & Organization Officer |
| Mr. Steffen Lang Ph.D. | Pres of Operations |
| Ms. Marie-France Tschudin | Pres of Innovative Medicines International & Chief Commercial Officer |
| Mr. Richard Saynor | Chief Exec. Officer of Sandoz |
| Paul Penepent | Head of Group Financial Reporting and Accounting |
| Dr. Samir Shah M.D. | Global Head of Investor Relations |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 1.5221 |
|---|---|
| Trailing PE: | 2.7757 |
| Price-to-Book MRQ: | 0.5771 |
| Price-to-Sales TTM: | 19.8441 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 101703 |